Uncategorized - April 10, 2024
HOUSTON, April 10, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain first-quarter 2024 financial […]
Read More
Uncategorized - April 10, 2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing […]
Read More
Uncategorized - April 10, 2024
Q1 2024 consolidated revenue of $16.2 million Report marks third consecutive quarter of near-flat-to-positive Adjusted EBITDA1 FY2024 revenue guidance confirmed […]
Read More
Uncategorized - April 10, 2024
NORWOOD, Mass., April 10, 2024 (GLOBE NEWSWIRE) — Leading multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD) today […]
Read More
Uncategorized - April 10, 2024
Q1-2024 copper production of 16.0 million pounds, 2% over guidance Q1-2024 normalized cash cost1of $1.89 per pound, beating guidance by […]
Read More
Uncategorized - April 10, 2024
Significant copper and molybdenum intersections include: HM17: 0.93% CuEq over 12 meters from near surface including 4 m @ 1.52% […]
Read More
Uncategorized - April 10, 2024
Creating One of the Largest Gold Development Companies in the United States with an Enhanced Platform for Heap Leach GoldProduction from […]
Read More
Uncategorized - April 10, 2024
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a […]
Read More
Uncategorized - April 10, 2024
LOS ALTOS, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
Read More
Uncategorized - April 10, 2024
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused […]
Read More